Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 16,983 | 17,787 | 15,970 | 15,959 | 18,408 |
| Cost of Goods | 15,454 | 16,345 | 14,803 | 15,847 | 18,382 |
| Gross Profit | 1,529 | 1,442 | 1,167 | 112 | 26 |
| Operating Expenses | 807 | 669 | 509 | 438 | 811 |
| Operating Income | 722 | 772 | 659 | -326 | -785 |
| Other Income | 7,451 | 24 | 115 | 732 | -10,014 |
| Pre-tax Income | 8,173 | 796 | 774 | 407 | -10,799 |
| Income Tax | 104 | 301 | 306 | -26 | -805 |
| Net Income Continuous | 8,069 | 495 | 468 | 432 | -9,995 |
| Net Income | $8,069 | $495 | $468 | $432 | $-9,995 |
| EPS Basic Total Ops | 0.40 | 0.03 | 0.02 | 0.02 | -0.53 |
| EPS Basic Continuous Ops | 0.40 | 0.03 | 0.02 | 0.02 | -0.53 |
| EPS Diluted Total Ops | 0.40 | 0.03 | 0.02 | 0.02 | -0.53 |
| EPS Diluted Continuous Ops | 0.40 | 0.03 | 0.02 | 0.02 | -0.53 |
| EBITDA(a) | $1,524 | $1,487 | $1,167 | $112 | $45 |